5 research outputs found
A two-fly tracker that solves occlusions by dynamic programming: computational analysis of Drosophila courtship behaviour
Authentication and characterisation of a new oesophageal adenocarcinoma cell line: MFD-1.
New biological tools are required to understand the functional significance of genetic events revealed by whole genome sequencing (WGS) studies in oesophageal adenocarcinoma (OAC). The MFD-1 cell line was isolated from a 55-year-old male with OAC without recombinant-DNA transformation. Somatic genetic variations from MFD-1, tumour, normal oesophagus, and leucocytes were analysed with SNP6. WGS was performed in tumour and leucocytes. RNAseq was performed in MFD-1, and two classic OAC cell lines FLO1 and OE33. Transposase-accessible chromatin sequencing (ATAC-seq) was performed in MFD-1, OE33, and non-neoplastic HET1A cells. Functional studies were performed. MFD-1 had a high SNP genotype concordance with matched germline/tumour. Parental tumour and MFD-1 carried four somatically acquired mutations in three recurrent mutated genes in OAC: TP53, ABCB1 and SEMA5A, not present in FLO-1 or OE33. MFD-1 displayed high expression of epithelial and glandular markers and a unique fingerprint of open chromatin. MFD-1 was tumorigenic in SCID mouse and proliferative and invasive in 3D cultures. The clinical utility of whole genome sequencing projects will be delivered using accurate model systems to develop molecular-phenotype therapeutics. We have described the first such system to arise from the oesophageal International Cancer Genome Consortium project.Cancer Research UK, Medical Research CouncilThis is the final version of the article. It first appeared from Nature Publishing Group via http://dx.doi.org/10.1038/srep3241
Authentication and characterisation of a new oesophageal adenocarcinoma cell line: MFD-1 (vol 6, 32417, 2016)
Authentication and characterisation of a new oesophageal adenocarcinoma cell line: MFD-1
New biological tools are required to understand the functional significance of genetic events revealed
by whole genome sequencing (WGS) studies in oesophageal adenocarcinoma (OAC). The MFD-1 cell
line was isolated from a 55-year-old male with OAC without recombinant-DNA transformation. Somatic
genetic variations from MFD-1, tumour, normal oesophagus, and leucocytes were analysed with SNP6.
WGS was performed in tumour and leucocytes. RNAseq was performed in MFD-1, and two classic OAC
cell lines FLO1 and OE33. Transposase-accessible chromatin sequencing (ATAC-seq) was performed in
MFD-1, OE33, and non-neoplastic HET1A cells. Functional studies were performed. MFD-1 had a high
SNP genotype concordance with matched germline/tumour. Parental tumour and MFD-1 carried four
somatically acquired mutations in three recurrent mutated genes in OAC: TP53, ABCB1 and SEMA5A,
not present in FLO-1 or OE33. MFD-1 displayed high expression of epithelial and glandular markers and
a unique fingerprint of open chromatin. MFD-1 was tumorigenic in SCID mouse and proliferative and
invasive in 3D cultures. The clinical utility of whole genome sequencing projects will be delivered using
accurate model systems to develop molecular-phenotype therapeutics. We have described the first such
system to arise from the oesophageal International Cancer Genome Consortium project
Whole-genome sequencing provides new insights into the clonal architecture of Barrett's esophagus and esophageal adenocarcinoma
The molecular genetic relationship between esophageal adenocarcinoma (EAC) and its precursor lesion, Barrett's esophagus, is poorly understood. Using whole-genome sequencing on 23 paired Barrett's esophagus and EAC samples, together with one in-depth Barrett's esophagus case study sampled over time and space, we have provided the following new insights: (i) Barrett's esophagus is polyclonal and highly mutated even in the absence of dysplasia; (ii) when cancer develops, copy number increases and heterogeneity persists such that the spectrum of mutations often shows surprisingly little overlap between EAC and adjacent Barrett's esophagus; and (iii) despite differences in specific coding mutations, the mutational context suggests a common causative insult underlying these two conditions. From a clinical perspective, the histopathological assessment of dysplasia appears to be a poor reflection of the molecular disarray within the Barrett's epithelium, and a molecular Cytosponge technique overcomes sampling bias and has the capacity to reflect the entire clonal architecture.</p